Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Regulation and modulation of the NALCN channelosome

Project description

Characterising NALCN channelosome physiology

Neurons are excited – and can produce an action potential – when positive sodium ions flow into the cell through channels (pores) in the cell membrane. The sodium leak channel non-selective protein (NALCN) forms the ion channel of the NALCN channelosome (signalling proteins associated with the ion channel). Mutations of the NALCN channelosome cause a broad range of neurological and developmental diseases. NALCN channelosome physiology is poorly understood and no treatment targeting the channelosome is available. To address these gaps and with the support of the Marie Skłodowska-Curie Actions programme, the TUNENALCN project aims to characterise the regulation of the NALCN channelosome and identify and characterise proteins that can modulate NALCN function.

Objective

The sodium leak channel (NALCN) is the ion-channel subunit of the NALCN channelosome, additionally containing UNC79, UNC80 and Fam155. NALCN controls the resting membrane potential (RMP) in excitable tissue (e.g. brain and myometrium) by an inward current of positively charged (sodium) ions that depolarizes the cell membrane, sensitizing the cell to excite (activate). NALCN is essential for survival. Mutations in the NALCN channelosome cause loss- or gain of function of NALCN currents which result in severe developmental disorders IHPRF and CLIFAHDD. Yet, NALCN channelosome physiology is largely unknown and no selective or specific drug-like compounds targeting the NALCN channelosome exist.

I propose the objectives: I) to characterize regulation of the NALCN channelosome by endogenous protein partner interactions (PPIs), and II) to identify and characterize de novo designer proteins that modulate NALCN function. I anticipate that this can inform on NALCN physiology and future therapeutic strategies to counteract NALCN loss- or gain of function and other excitability-related disorders.

I will perform the research at Copenhagen University in the lab of Professor Stephan Pless, an expert in the field. Objective I-II build onto novel in silico approaches where the Pless lab has identified PPIs based on protein co-evolution, tissue-co-expression, and disease association; and generated de novo designer proteins designed to bind the NALCN channelosome. I will elucidate the objectives experimentally by utilizing – and expanding – my experience in ion-channel research. In Objective I, I will use i) electrophysiology to study the functional impact of PPIs, ii) immunocytochemistry to interrogate sub-cellular localization and trafficking, and iii) biochemistry to determine direct interactions. In Objective II, I will perform electrophysiology on NALCN channelosome-expressing HEK cells and iPSC-derived neurons to find de novo designer proteins that inhibit or potentiate NALCN.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2024-PF-01

See all projects funded under this call

Coordinator

KOBENHAVNS UNIVERSITET
Net EU contribution
€ 247 553,28
Address
NORREGADE 10
1165 KOBENHAVN
Denmark
Region
Danmark Hovedstaden Byen København
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data